Nitroglycerin provocation in normal subjects is not a useful human migraine model?
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Nitroglycerin provocation in normal subjects is not a useful human migraine model? / Tvedskov, J F; Iversen, Helle Klingenberg; Olesen, J; Tfelt-Hansen, P.
In: Cephalalgia : an international journal of headache, Vol. 30, No. 8, 08.2010, p. 928-32.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Nitroglycerin provocation in normal subjects is not a useful human migraine model?
AU - Tvedskov, J F
AU - Iversen, Helle Klingenberg
AU - Olesen, J
AU - Tfelt-Hansen, P
PY - 2010/8
Y1 - 2010/8
N2 - Provoking delayed migraine with nitroglycerin in migraine sufferers is a cumbersome model. Patients are difficult to recruit, migraine comes on late and variably and only 50-80% of patients develop an attack. A model using normal volunteers would be much more useful, but it should be validated by testing the response to drugs of known efficacy in acute migraine. Furthermore, treatment during headache rather than pretreatment is the most naturalist method. To fulfil these requirements we used continuous long-lasting infusion of glyceryl trinitrate (GTN) 0.2 microg kg-1 min-1 for 140 min and gave aspirin 1000 mg, zolmitriptan 5 mg or placebo to normal healthy volunteers. The design was double-blind, placebo-controlled three-way crossover. Our hypothesis was that these drugs would be effective in the treatment of the mild constant headache induced by long-lasting GTN infusion. The headaches did not fulfil the International Headache Society diagnostic criteria for migraine without aura. Moreover, there was no effect on headache of either zolmitriptan or aspirin. Thus our hypothesis was disproved and we conclude that our model is not valid for the testing of new acute antimigraine drugs. Our experiment suggests that headache caused by direct nitric oxide (NO) action in the continued presence of NO is very resistance to analgesics and to specific acute migraine treatments. This suggests that NO works very deep in the cascade of events associated with vascular headache, whereas tested drugs work higher in the cascade. The model suggested here should therefore be tested with other headache/migraine-provoking agents that supposedly work higher in the cascade of events. The need for human models persists, but the solution to this problem is still pending.
AB - Provoking delayed migraine with nitroglycerin in migraine sufferers is a cumbersome model. Patients are difficult to recruit, migraine comes on late and variably and only 50-80% of patients develop an attack. A model using normal volunteers would be much more useful, but it should be validated by testing the response to drugs of known efficacy in acute migraine. Furthermore, treatment during headache rather than pretreatment is the most naturalist method. To fulfil these requirements we used continuous long-lasting infusion of glyceryl trinitrate (GTN) 0.2 microg kg-1 min-1 for 140 min and gave aspirin 1000 mg, zolmitriptan 5 mg or placebo to normal healthy volunteers. The design was double-blind, placebo-controlled three-way crossover. Our hypothesis was that these drugs would be effective in the treatment of the mild constant headache induced by long-lasting GTN infusion. The headaches did not fulfil the International Headache Society diagnostic criteria for migraine without aura. Moreover, there was no effect on headache of either zolmitriptan or aspirin. Thus our hypothesis was disproved and we conclude that our model is not valid for the testing of new acute antimigraine drugs. Our experiment suggests that headache caused by direct nitric oxide (NO) action in the continued presence of NO is very resistance to analgesics and to specific acute migraine treatments. This suggests that NO works very deep in the cascade of events associated with vascular headache, whereas tested drugs work higher in the cascade. The model suggested here should therefore be tested with other headache/migraine-provoking agents that supposedly work higher in the cascade of events. The need for human models persists, but the solution to this problem is still pending.
KW - Adult
KW - Analgesics
KW - Anti-Inflammatory Agents, Non-Steroidal
KW - Aspirin
KW - Cross-Over Studies
KW - Double-Blind Method
KW - Female
KW - Humans
KW - Infusions, Intravenous
KW - Male
KW - Migraine Disorders
KW - Models, Biological
KW - Nitroglycerin
KW - Oxazolidinones
KW - Serotonin Receptor Agonists
KW - Tryptamines
KW - Vasodilator Agents
KW - Young Adult
U2 - 10.1111/j.1468-2982.2009.02014.x
DO - 10.1111/j.1468-2982.2009.02014.x
M3 - Journal article
C2 - 19740120
VL - 30
SP - 928
EP - 932
JO - Cephalalgia
JF - Cephalalgia
SN - 0800-1952
IS - 8
ER -
ID: 128982991